Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-17

Clinical Trial Update: ToleroMune Ragweed Follow up Study

View source ↗

Summary

Update on a completed follow-up clinical trial of ToleroMune Ragweed for ragweed allergy with rhinoconjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ToleroMune Ragweed (ToleroMune Ragweed)

Snippet

Sponsor: Circassia Limited | Conditions: Ragweed Allergy, Rhinoconjunctivitis | Status: COMPLETED